Root Financial Partners’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$351 Buy
+72
New +$415 ﹤0.01% 3354
2026
Q2
– Sell
-72
Closed -$322 – 2975
2026
Q1
$322 Buy
+72
New +$335 ﹤0.01% 3010

Other funds holding TSHA

Root Financial Partners's TSHA Position: Q3 2026 in Review

Root Financial Partners opened a new position in Taysha Gene Therapies (TSHA) in Q3 2026: 72 shares worth $351. The stake represents ﹤0.01% of the portfolio and ranks #3354 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in TSHA as recently as Q1 2026.

Root Financial Partners first reported a position in TSHA in Q1 2026 and has held it in 2 quarters since. 205 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.

  • Root Financial Partners held 72 shares of Taysha Gene Therapies worth $351 as of Q3 2026.
  • Taysha Gene Therapies was a new Root Financial Partners position in Q3 2026.
  • Taysha Gene Therapies made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3354 holding.
  • Root Financial Partners first reported a position in Taysha Gene Therapies in Q1 2026 and has held it in 2 quarters since.
  • 205 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.